Using Hypnosis to Help Children Undergoing a Difficult Medical Procedure

This study has been completed.
Sponsor:
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00226850
First received: September 12, 2005
Last updated: September 23, 2005
Last verified: September 2005
  Purpose

This study examined whether a hypnosis intervention, compared to standard care, could help reduce distress and pain for children undergoing an invasive medical procedure.


Condition Intervention Phase
Voiding Cystourethrogram (VCUG)
Behavioral: hypnosis
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label

Further study details as provided by Stanford University:

  Eligibility

Ages Eligible for Study:   5 Years to 18 Years
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • The child: (1) was scheduled for an upcoming VCUG ; (2) must have undergone at least one previous VCUG; (3) was at least 4 years of age at the time of the previous VCUG; (4) experienced distress during the previous VCUG; and (5) both child and participating parent were English speaking.

Exclusion Criteria:

  • Not meeting any of the above criteria.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00226850

Locations
United States, California
Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine
Stanford, California, United States, 94305-5718
Lucile Packard Children's Hospital
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Study Director: Lisa D. Butler, Ph.D. Stanford University
Principal Investigator: David Spiegel, M.D. Stanford University
Principal Investigator: Linda D Shortliffe, M.D. Stanford University
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00226850     History of Changes
Other Study ID Numbers: 1HUK610
Study First Received: September 12, 2005
Last Updated: September 23, 2005
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on August 21, 2014